Best Life Sciences Companies in Las Vegas, United States
The 62 best Life Sciences companies in Las Vegas, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: JanOne.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Las Vegas
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JanOne Developer of drugs for treating pain, heart disease, and diabetic neuropathy | $27M | 194 mo ago | Public | Tony Isaac CEO | 1983 | — | — | — |
| 2 | Regeneca Manufacturing and marketing a range of branded dietary supplements | $19M | 180 mo ago | Series A | — | 2011 | — | — | — |
| 3 | Noninvasive Medical Technologies Noninvasive patient monitoring systems | $6M | 201 mo ago | Deadpooled | Ronald McCaughan CEO | 2003 | — | — | — |
| 4 | iDrink Beverages Provider of nano hydration system to deliver nutrients | $3M | 104 mo ago | Funding Raised | Neil Fineman CEO | 2014 | — | — | — |
| 5 | Medical Imaging Corp Online slot gaming platform with maxwin opportunities and deposit options | $2M | 162 mo ago | Public | Mitchell Geisler CEO | 2000 | — | 646 patents Developing and producing contrast agents and radiopharmaceuticals for medical imaging | — |
| 6 | Heligenics Provider of an assay platform for genetic diagnosis | $1M | 15 mo ago | Series A | Martin Schiller Founder | 2017 | — | 23 patents Engineered interferon‑beta cytokine therapeutics and functional genomics screening platforms | — |
| 7 | Isotropic Imaging Innovating breast cancer imaging with dedicated 3D breast CT technology | $865K | 16 mo ago | Public | Robert Thast CEO | 2016 | — | — | 1 partnership |
| 8 | Rollins Medical Soluitons Innovative oxygen mask solutions improving patient safety, efficiency, and cost-effectiveness | $475K | 132 mo ago | Seed | Offord Rollins CEO | 2010 | — | — | — |
| 9 | J&M Urinary Systems Developer of catheters | $392K | 123 mo ago | Seed | Cheryl Mitts Co-Founder | 2012 | — | — | — |
| 10 | EnzymeBioSystems Developer of therapies for treating cancer | $390K | 104 mo ago | Deadpooled | John Harper CEO | 2009 | — | — | — |
| 11 | Imatrex Provider of non-invasive medical imaging devices | $250K | 108 mo ago | Seed | Douglas P Boyd CEO | 2002 | — | 22 patents Advanced magnetic beam steering and dose‑optimization for medical X‑ray/therapy systems | — |
| 12 | Zyppah Anti-snoring mouthguard solutions for better sleep and healthier relationships | $185K | 22 mo ago | Acquired | Jonathan Greenburg Founder & CEO | 2012 | Cart FunctionalityShopifySentry+37 | — | — |
| 13 | GreenBroz Provider of harvesting systems for the cannabis and hemp industry | $150K | 141 mo ago | Seed | Cullen Raichart Founder & CEO | 2012 | Cart FunctionalityHubSpot CMS HubMaterial Design Lite+22 | 5 patents Automated cannabis flower trimming and belt-based bud sorting machinery | — |
| 14 | Rhinal Therapeutics Developer of regenerative therapies for the treatment of diabetes | $20K | 11 mo ago | Seed | Frank Puglisi Co-Founder | 2023 | — | — | — |
| 15 | GBSciences Developer of cannabinoid therapeutics for cardiovascular and other conditions | — | 34 mo ago | Public | John Poss CEO | 1967 | — | — | — |
Top 12 Life Sciences companies in Las Vegas
#1
Series A · Las Vegas, Nevada · founded 2017 · 5 employees$1.2Mraised▾
Heligenics has developed a genetic diagnostic assay for genetic testing. The company's proprietary product includes the in-vitro GigaAssay. It is a gene-screening system that is able to analyze the impact of all potential amino acid substitutions in the functional target protein. It is used for diagnostic purposes.
- Mar 2025Grant (prize money)$398.5K
- Aug 2024Series A$2.6M
- Feb 2023Grant (prize money)$398.5K
- Dec 2020Seed$1.2M
#2
Public · Las Vegas, Nevada · founded 2016$865.2Kraised▾
Innovating breast cancer imaging with dedicated 3D breast CT technology, the company focuses on improving breast cancer detection, especially in women with dense breast tissue. They offer a dedicated breast CT platform providing true 3D imaging without compression, boasting high spatial resolution. The company is preparing for a pivotal clinical study, aiming to establish its technology as a leader in breast imaging. The company operates in the global breast imaging market, driven by the demand for earlier and more accurate cancer detection. The company utilizes advanced technology and a focused clinical strategy, offering a unique opportunity to invest in a fast-growing sector. The company is involved in medical imaging, clinical research, and commercialization, advancing its technology from proven science to real-world impact.
- Feb 2025Post IPO$320.8K
- Sep 2023Post IPO$523.4K
- Nov 2020Post IPO$20.9K
#3
Seed · Las Vegas, Nevada · founded 2023$20Kraised▾
Developer of regenerative therapies for the treatment of diabetes. It offers a patented intranasal powder GLP-1 t3 treatment for compliance and adherence for pediatrics.
- Jul 2025Seed$20K
#4
Acquired · Las Vegas, Nevada · founded 2012 · 5 employees$185Kraised▾
Anti-snoring mouthguard solutions for better sleep and healthier relationships. They offer clinically proven, dual-action technology designed to stop snoring by addressing its root cause: the tongue. Their product gently holds the tongue in place, preventing airway blockage. They provide a custom comfort fit through a simple customization process. They offer a risk-free trial with a full refund guarantee. Their solutions are biomechanically engineered and backed by a scientific advisory board. They also support Breast Cancer Awareness with a portion of proceeds from specific products donated to the Susan G. Komen Foundation. They offer products like mouth tape and nasal strips. The website offers features like cart, login, shop now, science, reviews, search, and subscription.
- Aug 2024Seed$60K
- Apr 2023Seed$125K
#5
Public · Las Vegas, Nevada · founded 1983 · 120 employees$26.8Mraised▾
JanOne is developing drugs for treating pain. The drug is in phase 2a clinical trials that support the use of sodium nitrite for the treatment and prevention of Peripheral Artery Disease (PAD) and as a non-addictive treatment for diabetic neuropathy. It has developed JAN 101 for treating peripheral artery diseases.
- Apr 2010Post IPO$1.8M
- Conventional Debt$25M
#6
Series A · Las Vegas, Nevada · founded 2011$19.3Mraised▾
Manufacturing and marketing a range of branded dietary supplements
#7
Deadpooled · Las Vegas, Nevada · founded 2003 · 9 employees$6.3Mraised▾
NMT has brought to market a comprehensive suite of noninvasive hemodynamic monitoring and assessment tools and solutions that provide both military and civilian medical specialists with real-time situational awareness and critical lifesaving intelligence. Its products : (i) the IQ2, noninvasive systems offers an accurate method to asses and evaluate cardiac function; (ii) the ZOE, fluid status monitor is a non-invasive, battery powered impedance monitor designed as an 'early warning' monitor for determining changes in the fluid status of patients with fluid management problems; (iii) the NcIQ noncontact sensor for the early intervention of first responder assistance and casualty management, and; (iv) the ETag Sensor, casualty management system.
- Sep 2009Series A$6.3M
#8
Funding Raised · Las Vegas, Nevada · founded 2014$3.3Mraised▾
Provider of nano hydration system to deliver nutrients. Their products include multivitamin water by using a nanotechnology process infuses with vitamins, electrolytes, and trace minerals without flavors or colors.
- Oct 2017Conventional Debt$930.8K
- Mar 2014Conventional Debt$2.4M
#9
Public · Las Vegas, Nevada · founded 2000 · 40 employees$2.3Mraised▾
Online slot gaming platform with maxwin opportunities and deposit options. This platform provides access to a variety of online slot games, emphasizing opportunities for players to achieve "maxwin" jackpots. It highlights the availability of different deposit methods, including options like QRIS and Dana, to facilitate easy transactions. The platform promotes various slot games, including those from providers like PG Soft and Pragmatic Play, and discusses strategies for maximizing winnings, such as understanding RTP (Return to Player) rates. It also mentions the availability of demo slots for practice and the importance of choosing trusted sites for a secure gaming experience. The platform caters to both new and experienced players, offering bonuses and promotions to enhance the gaming experience.
- Dec 2012Post IPO$1.9M
- Mar 2009Post IPO$453.1K
#10
Seed · Las Vegas, Nevada · founded 2010 · 2 employees$475Kraised▾
Innovative oxygen mask solutions improving patient safety, efficiency, and cost-effectiveness. This company focuses on respiratory therapy, offering a patented replacement mask designed for all oxygen needs, eliminating the need for multiple mask types. The SmartMask design allows for unique medication delivery and enhanced patient comfort. The company aims to reduce waste, improve oxygen consumption, and address safety concerns associated with traditional oxygen therapy methods. They offer a single SKU for adults, simplifying inventory management for hospitals. This company is committed to delivering high-quality service and support, promoting better patient outcomes and cost savings for healthcare institutions.
- 2015Seed$425K
- Sep 2011Seed$50K
#11
Deadpooled · Las Vegas, Nevada · founded 2009$389.8Kraised▾
Enzyme Bio Systems is developing therapies for treating cancer. Their lead candidate, Amoorain, which isolated from the stem bark of the Indian medicinal plant Amoora rohituka. Its a synthetic oleanane triterpenoid exerts a chemopreventive effect through antiproliferative and proapoptotic actions. The candidate has completed the preclinical studies.
- Oct 2017Series A$389.8K
#12
Seed · Las Vegas, Nevada · founded 2012 · 3 employees$392Kraised▾
J&M Urinary Systems has developed catheters used for the treatment of urinary incontinence. The company is developing both indwelling and intermittent catheters. It has also developed urinary collection bags. The products are still under development.
- Mar 2016Seed$392K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.